Article Details
Retrieved on: 2023-01-13 15:17:15
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Primcyv is a targeted therapy containing the active constituent palbociclib, a first-in-class CDK 4/6 inhibitor indicated in combination with an ...
Article found on: economictimes.indiatimes.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here